MRZK Pharma
0439.203.330 · rovalta.com · 24/09/2026
ACTIVE
MRZK Pharma
Financial year 2025 · Closed on 31/12/2025
Net result
35,8 k €
+4,9 %over 1 yearGross margin
211,4 k €
+24,0 %over 1 yearEquity
556,3 k €
+6,9 %over 1 yearWorkforce
2,8 ETP
0,0 %over 1 yearOverview
Identity
Source · BCE/KBOMRZK Pharma is a Private limited company incorporated in 1989. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Hamme (Vl.). It employs on average 2,8 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0439.203.330
- Incorporation
- 27/12/1989
- Legal form
- Private limited company
- Registered office
- Dorp 11
9220 Hamme (Vl.) · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 2,8 ETP
Activities (NACE)
Joint committees (1)
- 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 20 filingsTrend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 211,4 k € | +24.0% | 170,5 k € | +20.6% | 141,4 k € | -30.8% | 204,2 k € | +6.6% | 191,5 k € |
| EBITDA | 47,5 k € | +20.5% | 39,4 k € | -38.1% | 63,7 k € | -46.6% | 119,3 k € | -2.1% | 121,8 k € |
| Operating result | 41 k € | +20.8% | 34 k € | -43.0% | 59,6 k € | -48.8% | 116,4 k € | -1.9% | 118,6 k € |
| Net result | 35,8 k € | +4.9% | 34,2 k € | -45.1% | 62,2 k € | -39.7% | 103,2 k € | +5.4% | 97,9 k € |
| Balance sheet | |||||||||
| Equity | 556,3 k € | +6.9% | 520,4 k € | +7.0% | 486,3 k € | -69.8% | 1,6 M € | +6.9% | 1,5 M € |
| Total assets | 721,1 k € | +5.3% | 684,5 k € | +0.4% | 682 k € | -61.1% | 1,8 M € | +7.7% | 1,6 M € |
| Cash | 21,6 k € | -10.4% | 24,1 k € | +54.7% | 15,6 k € | -12.3% | 17,7 k € | +15.9% | 15,3 k € |
| Debts | 164,9 k € | +0.5% | 164,1 k € | -16.1% | 195,7 k € | +36.5% | 143,3 k € | +18.0% | 121,5 k € |
| Other | |||||||||
| Workforce | 2,8 ETP | 0.0% | 2,8 ETP | +64.7% | 1,7 ETP | +6.2% | 1,6 ETP | +60.0% | 1,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/2025Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 12/05/2026 | 16/06/2025 | 11/06/2024 | 09/06/2023 | 07/06/2022 | 14/06/2021 |
| General meeting | 02/05/2026 | 02/05/2025 | 03/05/2024 | 05/05/2023 | 06/05/2022 | 07/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 02/05/2026 | 12/05/2026 | Dutch | |
| Abridged model | 31/12/2024 | 02/05/2025 | 16/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 03/05/2024 | 11/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 05/05/2023 | 09/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 06/05/2022 | 07/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 07/05/2021 | 14/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 02/05/2020 | 13/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 03/05/2019 | 09/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 04/05/2018 | 28/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 05/05/2017 | 10/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 06/05/2016 | 13/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 02/05/2015 | 27/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 02/05/2014 | 21/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 03/05/2013 | 27/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 04/05/2012 | 17/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 06/05/2011 | 26/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 07/05/2010 | 05/07/2010 | Dutch | |
| Full model | 31/12/2008 | 29/05/2009 | 29/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 30/05/2008 | 25/06/2008 | Dutch | |
| Abridged model | 31/12/2006 | 31/05/2007 | 28/06/2007 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Publications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates24/07/2026ONTSLAGEN - BENOEMINGEN
- Mandates02/12/2022ONTSLAGEN - BENOEMINGEN
- Mandates07/01/2021STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Registered office12/06/2018MAATSCHAPPELIJKE ZETEL
- Mandates13/12/2016ONTSLAGEN - BENOEMINGEN
- Mandates26/05/2010BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Mandates20/08/2009ONTSLAGEN - BENOEMINGEN
- Mandates30/01/2008ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202535,8 k €↑
- 2024Annual accounts 202434,2 k €↓
- 2024Name change025 - MRZK Pharma
- 2023Annual accounts 202362,2 k €↓
- 2022Annual accounts 2022103,2 k €↑
- 2021Annual accounts 202197,9 k €↑
- 2021Name changeMRZK Pharma
- 2020Annual accounts 202062,2 k €↑
- 2019Annual accounts 201940,3 k €↓
- 2018Annual accounts 201847,7 k €↓
- 2017Annual accounts 201751,6 k €↓
- 2016Annual accounts 201667,8 k €↓
- 2015Annual accounts 201573,8 k €↓
- 2014Annual accounts 201475,9 k €↓
- 2013Annual accounts 201376,9 k €↑
- 2012Annual accounts 201274,9 k €↑
- 2011Annual accounts 201148,1 k €↓
- 2010Annual accounts 201084,9 k €↑
- 2009Annual accounts 200968,2 k €↑
- 2008Annual accounts 200823 k €↓
- 2007Annual accounts 200776,5 k €↑
- 2006Annual accounts 200646,9 k €
- 27/12/1989IncorporationPrivate limited company